This announcement is a separate document:
海特生物:武汉海特生物制药股份有限公司2022年半年度报告(更正后)
Haite Biotech: 2022 Semi-Annual Report of Wuhan Haite Biopharmaceutical Co., Ltd. (after correction)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.